Secondary Stroke Prevention in Cryptogenic Stroke and Embolic Stroke of Undetermined Source (ESUS)
- 13 July 2017
- journal article
- review article
- Published by Springer Nature in Current Neurology and Neuroscience Reports
- Vol. 17 (9) , 64
Abstract
The purpose of the study was to review the literature on cryptogenic stroke and embolic stroke of undetermined stroke (ESUS). Cryptogenic stroke according to TOAST criteria is a stroke which is not due to cardiogenic embolism, small vessel disease with lacunes or large vessel disease of brain supplying arteries. In the context of secondary stroke prevention studies, cryptogenic stroke is not operationally defined.Keywords
This publication has 26 references indexed in Scilit:
- Closure of Patent Foramen Ovale versus Medical Therapy after Cryptogenic StrokeNew England Journal of Medicine, 2013
- Percutaneous Closure of Patent Foramen Ovale in Cryptogenic EmbolismNew England Journal of Medicine, 2013
- Vitamin K antagonists versus antiplatelet therapy after transient ischaemic attack or minor ischaemic stroke of presumed arterial originCochrane Database of Systematic Reviews, 2012
- Closure or Medical Therapy for Cryptogenic Stroke with Patent Foramen OvaleNew England Journal of Medicine, 2012
- Atherosclerotic Disease of the Proximal Aorta and the Risk of Vascular Events in a Population-Based CohortStroke, 2009
- Aortic Arch Plaques and Risk of Recurrent Stroke and DeathCirculation, 2009
- Atherosclerosis of the aorta: Risk factor, risk marker, or innocent bystander?JACC, 2004
- Recurrent Cerebrovascular Events Associated with Patent Foramen Ovale, Atrial Septal Aneurysm, or BothNew England Journal of Medicine, 2001
- A Comparison of Warfarin and Aspirin for the Prevention of Recurrent Ischemic StrokeNew England Journal of Medicine, 2001
- Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.Stroke, 1993